Karuna Therapeutics (KRTX) Competitor Comparison
We are evaluating the key criteria listed to compare Karuna Therapeutics (KRTX) against its competitors in the Biotechnology industry.
Market Capitalization
14 / 368Gross Profits
100 / 278Total Revenue
199 / 300EBITDA
319 / 337Free Cashflow
330 / 352Quick Ratio
14 / 357Earnings per Share
339 / 359Dividend yield
0 / 6Total Cash
16 / 358Performance 3 years
24 / 368Performance 5 years
4 / 368Performance 10 years
6 / 368Linearity 3 years
349 / 368Linearity 5 years
366 / 368Linearity 10 years
365 / 368Total Rank
172 / 368Dividend Rank
178 / 368Valuation Rank
269 / 368Piotroski Rank
137 / 368Muliplier Rank
132 / 368Dividend yield - KRTX ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.